Durham, NC, United States · North America
OncologyRare diseaseCell & gene therapyVaccines
FDAEMAPMDANMPA
SCALE 270 studies
Open to sponsorsSterile / advanced-therapy specialistView OncologyCell & gene therapyRare diseaseVaccines
NMPAFDAEMAPMDA
SCALE 270 studies
Open to sponsorsSterile / advanced-therapy specialistView OncologyVaccinesRare disease
NMPAFDAEMAPMDA
SCALE 270 studies
Open to sponsorsSterile / advanced-therapy specialistView Oncology
FDAEMAPMDANMPA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView OncologyVaccines
PMDAFDAEMANMPA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView Princeton, NJ, United States · United States
OncologyInfectious diseaseVaccines
FDAEMAMHRAHealth Canada
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView London, United Kingdom · Europe
OncologyRare disease
FDAEMAPMDAMHRA
SCALE 230 studies
Open to sponsorsSelectiveView Suzhou, China · North America
NMPAFDAEMA
SCALE 20 studies
Open to sponsorsGeneral clinicalView Nottingham, United Kingdom · Europe
SCALE 30 studies
Open to sponsorsGeneral clinicalView Nijmegen, Netherlands · Europe
SCALE 20 studies
Open to sponsorsGeneral clinicalView